Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report)'s stock had its "sell (d)" rating reaffirmed by investment analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.
Other equities research analysts have also issued research reports about the stock. Canaccord Genuity Group reissued a "hold" rating and set a $2.50 target price (down previously from $6.50) on shares of Bioceres Crop Solutions in a research note on Wednesday, September 10th. Wall Street Zen downgraded shares of Bioceres Crop Solutions from a "hold" rating to a "sell" rating in a report on Saturday, September 13th. Lake Street Capital cut their price target on shares of Bioceres Crop Solutions from $8.00 to $5.00 and set a "buy" rating on the stock in a report on Wednesday, September 10th. Brookline Capital Management downgraded shares of Bioceres Crop Solutions from a "strong-buy" rating to a "hold" rating in a report on Thursday, August 21st. Finally, Oppenheimer set a $5.00 price target on shares of Bioceres Crop Solutions in a report on Tuesday, September 9th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $4.17.
Get Our Latest Stock Report on Bioceres Crop Solutions
Bioceres Crop Solutions Trading Up 2.3%
Bioceres Crop Solutions stock traded up $0.03 during midday trading on Wednesday, reaching $1.33. The stock had a trading volume of 754,605 shares, compared to its average volume of 282,147. The firm's fifty day simple moving average is $2.46 and its two-hundred day simple moving average is $3.73. Bioceres Crop Solutions has a twelve month low of $1.20 and a twelve month high of $7.80. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74. The firm has a market cap of $83.40 million, a price-to-earnings ratio of -1.64 and a beta of 0.33.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the stock. PDT Partners LLC increased its holdings in shares of Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company's stock worth $126,000 after purchasing an additional 10,449 shares during the period. Jane Street Group LLC bought a new position in shares of Bioceres Crop Solutions during the 2nd quarter worth about $202,000. Ardsley Advisory Partners LP increased its holdings in shares of Bioceres Crop Solutions by 4.7% during the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company's stock worth $4,441,000 after purchasing an additional 45,000 shares during the period. Avanza Fonder AB increased its holdings in shares of Bioceres Crop Solutions by 62.9% during the 2nd quarter. Avanza Fonder AB now owns 26,164 shares of the company's stock worth $117,000 after purchasing an additional 10,099 shares during the period. Finally, Jones Financial Companies Lllp increased its holdings in shares of Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock worth $25,000 after purchasing an additional 5,339 shares during the period. Institutional investors own 17.68% of the company's stock.
Bioceres Crop Solutions Company Profile
(
Get Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.